Guide to using AAV vectors in gene therapy
Drug Discovery World
FEBRUARY 8, 2024
In 2023, DDW hosted a webinar, ‘A comprehensive guide to using adeno-associated virus (AAV) vectors in gene therapy’, supported by Azenta Life Sciences.
Bioinformatics Molecular Biology Virus 
147 
Guide to using AAV vectors in gene therapy
Drug Discovery World
OCTOBER 3, 2023
Earlier this year, DDW hosted a webinar, ‘A comprehensive guide to using adeno-associated virus (AAV) vectors in gene therapy’, supported by Azenta Life Sciences.
Join 42,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Therapeutic antibody potential in 2024
Drug Discovery World
MAY 1, 2024
The company also partnered with a top 20 pharma company and has been successful in identifying antibody candidates for a target of interest, with greater diversity (2.3x) and accuracy compared to alternative bioinformatics pipeline selection methods.
A new viral surveillance system in West Africa is showing the world how to prevent the next pandemic
Broad Institute
APRIL 25, 2024
The project is a collaboration between the Broad and the African Center of Excellence for Genomics of Infectious Diseases (ACEGID) at Redeemer’s University outside Lagos in Nigeria, where Happi is a professor of molecular biology and genomics. Through Sentinel, we are creating a world that is equitable.
What to expect from PEGS Europe 2023: Day 2
Drug Discovery World
NOVEMBER 9, 2023
Phil Leighton, PhD, Senior Director, Molecular Biology, OmniAb, on: ‘Heavy chain-only transgenic chickens produce human antibodies with robust immune repertoires and high-affinity binding’. The session ends with two presentations and two luncheon presentations.
FAIR Game: making data work harder in the race to market
Drug Discovery World
OCTOBER 17, 2022
Christof Gänzler gained his doctorate in molecular biology from the German Cancer Center (dkfz) in Heidelberg/Germany working on Human Papilloma Virus vaccines. Previously he held positions at LION Bioscience as a Scientific Bioinformatics Consultant before joining TIBCO Spotfire followed by ZephyrHealth. Reference: .
Synthetic biology tools advancing and accelerating drug discovery efforts
Drug Discovery World
NOVEMBER 15, 2022
As such, the synthesis of DNA oligonucleotides for routine molecular biology applications is often outsourced to service provider companies that operate DNA synthesisers to meet these demands. . So, we wondered if we could design a therapeutic that essentially works against all variants of concern,” shares Dr Jewett. .
Let's personalize your content